Route 92 Medical has announced the appointment of Jonathan Kennedy to the role of chief financial officer. In this role, Kennedy will be responsible for overseeing all financial management for the company, reporting directly to CEO and founder Tony Chou.
“Route 92 Medical’s technology offers uniquely disruptive solutions in the rapidly growing stroke treatment market,” said Kennedy. “The company is well-positioned for long-term growth, continued product innovation, and meaningful improvements in patient outcomes, which makes this an exciting time to join. Expanding the company’s critical business infrastructure to support this type of growth will accelerate Route 92 Medical’s success.”
Kennedy joins Route 92 after an eight-year stint as CEO and chief financial officer at Natus Medical—a neurology, newborn care, hearing and balance company. At Natus, he helped build a multi-site, multinational business via acquisition, innovation, and best-in-class customer service. Prior to that, Kennedy served as senior vice president and chief financial officer for Intersil Corporation, now part of Renesas, which designs and manufactures high-performance analogue semiconductors.
Kennedy holds a Bachelor of Science (BS) degree in business administration and accounting, and a Master of Science (MS) degree in accounting, from the University of Central Florida (Orlando, USA). He also earned his Certified Public Accountant (CPA) licensure in Florida.
“Jonathan has managed very large product portfolios and complex business situations in hypercompetitive markets,” said Chou. “He is a leader with a demonstrated history of delivering outstanding financial growth across a variety of companies and industries. Route 92 Medical is fortunate to have someone with his extensive experience joining [its] team as we work together to transform neurovascular intervention.”
